ASRT vs MCO · rev $125.0M vs P/E 33, rev $7.72B
Assertio Therapeutics Inc (ASRT) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported MCO revenue for 2025-12-31 was $7.72B. Net income was $2.46B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
ASRT currently screens at market cap $151.5M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the ASRT and MCO stock pages for the full models.
Not investment advice.